COPD biomarker fibroinogen awaits results of FDA review

被引：0
|
作者：
Attwood, Claire
机构：
来源：
EXPERT REVIEW OF RESPIRATORY MEDICINE | 2013年 / 7卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：443 / 443
页数：1
相关论文
共 50 条
  • [31] What is the best biomarker of COPD stability?
    Pertseva, Tetyana
    Basina, Bogdana
    Konopkina, Lyudmila
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [32] RESULTS OF THE SECOND UPDATE OF THE COPD SELF-MANAGEMENT COCHRANE REVIEW
    Zwerink, M.
    Brusse-Keizer, M.
    Van der Valk, P.
    Frith, P.
    Van der Palen, J.
    Effing, T.
    RESPIROLOGY, 2014, 19 : 25 - 25
  • [33] A testing approach based on tiny doses still awaits big results
    Coombs, Amy
    NATURE MEDICINE, 2008, 14 (08) : 796 - 796
  • [34] US FDA advised to approve aclidinium bromide for COPD
    Attwood, Claire
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2012, 6 (02) : 141 - 141
  • [35] The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review
    Tong, Xiang
    Wang, Dongguang
    Liu, Sitong
    Ma, Yao
    Li, Zhenzhen
    Tian, Panwen
    Fan, Hong
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 409 - 418
  • [36] Endovascular treatment for claudication still awaits long-term results
    Farber, Alik
    JOURNAL OF VASCULAR SURGERY, 2017, 66 (01) : 1 - 1
  • [37] A testing approach based on tiny doses still awaits big results
    Amy Coombs
    Nature Medicine, 2008, 14 : 796 - 796
  • [38] FDA will review Ketek
    不详
    CHEMICAL & ENGINEERING NEWS, 2006, 84 (47) : 58 - 58
  • [39] National Artificial Reef Plan awaits final review, adoption
    不详
    FISHERIES, 1998, 23 (09) : 41 - 41
  • [40] Review staff at FDA
    Goldhammer, A
    SCIENCE, 1997, 276 (5313) : 661 - 661
12345